8月份申万菱信医药先锋股票跌9% 垫底股基排行榜

Core Viewpoint - In August, the Shenwan Hongyuan Medical Pioneer Stock A/C fund experienced a significant decline, marking it as the only ordinary stock fund with a drop exceeding 9% during the month [1][3]. Fund Performance - The Shenwan Hongyuan Medical Pioneer Stock A/C fund recorded a decline of 9.48% and 9.52% respectively, placing it at the bottom of the performance rankings for ordinary stock funds in August [1]. - Since its inception, the fund has shown a return of -39.90% for A shares and -26.86% for C shares, with cumulative net values of 0.6010 yuan and 0.5925 yuan respectively as of September 1, 2025 [3][4]. - The fund's recent performance includes a 1-month decline of -5.98% for A shares and -6.01% for C shares, while the 1-year performance stands at 27.52% and 26.96% respectively [4]. Fund Holdings - As of the second quarter, the fund's top ten holdings included companies such as Angli Kang, Kangwei Century, and Sinocelltech, among others [1]. - Despite a recovery in the second quarter, the fund's performance in August indicates a significant underperformance compared to its peers, with poor quartile rankings across various time frames [1]. Management - The current fund manager, Yao Hongfu, has been managing the fund since July 19, 2022, and has a background in research and insurance [4].